<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药融圈 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-14T11:10:11+08:00</updated>
  <subtitle>药融圈PHARNEX汇聚数万医药大咖，得到数千家医药创业者鼎力支持，开展日常专题讲座。致力于成为“专业、前沿、权威、严谨”的医药行业资讯平台，以及项目、技术、工厂、融资、股权投资等资源整合平台。欢迎您关注药融圈，共同碰撞“药”的火花!</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>借鉴：Divi’s  Lab何以成为印度API三巨头之一</title>
    <updated>2020-11-13T21:11:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/HmWHN0T_sEAcoFxL5prYtQ</id>
    <link href="https://mp.weixin.qq.com/s/HmWHN0T_sEAcoFxL5prYtQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抢免费入场券｜谁将参与石家庄免费制剂技术会议？</title>
    <updated>2020-11-13T21:11:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/j4ri0wILw-Q71ogOQpWrpg</id>
    <link href="https://mp.weixin.qq.com/s/j4ri0wILw-Q71ogOQpWrpg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>推进仿创结合战略，聚焦多肽全产业链布局—翰宇药业</title>
    <updated>2020-11-13T21:11:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/Qnddlg8ygGzdLXNmLOOwTA</id>
    <link href="https://mp.weixin.qq.com/s/Qnddlg8ygGzdLXNmLOOwTA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【每日药闻】圣兆药物精耕高端复杂注射剂细分领域，借力中金拓宽资本之路；信达生物肿瘤药与自身免疫双轮驱动，持续快速增长可期...</title>
    <updated>2020-11-13T21:11:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/y1GnVtQWTj2njeuZOtd6JQ</id>
    <link href="https://mp.weixin.qq.com/s/y1GnVtQWTj2njeuZOtd6JQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>昆药集团IDH1抑制剂获批临床，研发投入约2569万元</title>
    <updated>2020-11-13T21:11:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/hj9x1cxqbn0eycZnKEJ-Tg</id>
    <link href="https://mp.weixin.qq.com/s/hj9x1cxqbn0eycZnKEJ-Tg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>补体新药！科越医药完成4600万美元融资，走出隐匿模式</title>
    <updated>2020-11-13T21:11:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/8S25zbRgkNgfaLjcwaA-Dw</id>
    <link href="https://mp.weixin.qq.com/s/8S25zbRgkNgfaLjcwaA-Dw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新锐|半年两轮融资1.3亿美元，Adimab孵化新锐开发新冠抗体</title>
    <updated>2020-11-13T21:11:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/XuazUmibW-Q-jGSc-zFAmQ</id>
    <link href="https://mp.weixin.qq.com/s/XuazUmibW-Q-jGSc-zFAmQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新药大家风云对话，2020中国新药创新者大会圆满落幕！</title>
    <updated>2020-11-13T19:23:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/lbQQS1Tqt0CQijZ6cScJSQ</id>
    <link href="https://mp.weixin.qq.com/s/lbQQS1Tqt0CQijZ6cScJSQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【重磅升级】药融云数据V2.0版本正式发布，医药数据免费查</title>
    <updated>2020-11-13T19:23:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/svVFuthuM8r1JOFnO0SDag</id>
    <link href="https://mp.weixin.qq.com/s/svVFuthuM8r1JOFnO0SDag" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【每日药闻】药明康德业务和投资双驱动，疫情下保持高增长；药石科技-收入快速恢复，砌块龙头成长趋势不变...</title>
    <updated>2020-11-13T19:23:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/qygIx0AXPMdI3p5i55vpow</id>
    <link href="https://mp.weixin.qq.com/s/qygIx0AXPMdI3p5i55vpow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【温江行收官】一流企业四川科伦、药明康德引药融圈企业家考察团成员频频点赞</title>
    <updated>2020-11-13T19:23:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/Wc_qkf0Opqwatkt5ONRn4A</id>
    <link href="https://mp.weixin.qq.com/s/Wc_qkf0Opqwatkt5ONRn4A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>11家，广西第一批化工园区公布（附6省已认定名单）</title>
    <updated>2020-11-13T19:23:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/sDfSci0Bld_tU505uk3-KQ</id>
    <link href="https://mp.weixin.qq.com/s/sDfSci0Bld_tU505uk3-KQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>复宏汉霖CD38抗体HLX15提交临床申请，研发投入约1511万元</title>
    <updated>2020-11-13T19:23:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/Hv5syBQOFVnihqc95fOaSg</id>
    <link href="https://mp.weixin.qq.com/s/Hv5syBQOFVnihqc95fOaSg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>四川科伦药业2注射液通过（含视同）一致性评价</title>
    <updated>2020-11-13T19:23:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/Trl3P3Bxdp1LlSqdTxrbAQ</id>
    <link href="https://mp.weixin.qq.com/s/Trl3P3Bxdp1LlSqdTxrbAQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>大咖云集，千人共聚，中国新药创新者大会再掀热潮！明日精彩继续</title>
    <updated>2020-11-13T19:23:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/gcHVcmAx37R00tQXO02tuw</id>
    <link href="https://mp.weixin.qq.com/s/gcHVcmAx37R00tQXO02tuw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅！费米子科技完成A轮融资，累计融资额上亿元</title>
    <updated>2020-11-12T19:27:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/xy7Jx2mlB4QzmZveifoKgw</id>
    <link href="https://mp.weixin.qq.com/s/xy7Jx2mlB4QzmZveifoKgw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>大咖云集，千人共聚，中国新药创新者大会再掀热潮！明日精彩继续</title>
    <updated>2020-11-12T19:27:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/9E7N7WoEaU3FoN0ws783iA</id>
    <link href="https://mp.weixin.qq.com/s/9E7N7WoEaU3FoN0ws783iA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【每日药闻】华大基因新冠检测试剂需求持续旺盛，常规业务逐步恢复；复星医药净利润增速远超营收，产品管线逐步丰富...</title>
    <updated>2020-11-12T19:27:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/8NcuxR7A6CnHchp7PjAz2g</id>
    <link href="https://mp.weixin.qq.com/s/8NcuxR7A6CnHchp7PjAz2g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>正大天晴：泊马度胺胶囊重磅获批，多发性骨髓瘤重磅药！11月12日45个批件待领取</title>
    <updated>2020-11-12T19:27:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/zCNTxAuO6_XJLHtRWQKpog</id>
    <link href="https://mp.weixin.qq.com/s/zCNTxAuO6_XJLHtRWQKpog" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>成都赜灵生物引进5款创新药，NLRP3抑制剂、RIP1/2抑制剂等值得关注</title>
    <updated>2020-11-12T19:27:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/iTsLCu1_2yv16HGxghiZtg</id>
    <link href="https://mp.weixin.qq.com/s/iTsLCu1_2yv16HGxghiZtg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>